Murine mobilized peripheral blood stem cells have a lower capacity than bone marrow to induce mixed chimerism and tolerance

American Journal of Transplantation

Volumn 8, Issue 10, 2008, Pages 2025-2036

  Koporc, Z ^a   Pilat, N ^a   Nierlich, P ^a   Blaha, P ^a   Bigenzahn, S ^a   Pree, I ^a   Selzer, E ^a   Sykes, M ^b   Muehlbacher, F ^a   Wekerle, T ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Costimulation blockade; Mixed chimerism; PBSC; Tolerance

Indexed keywords

ABATACEPT; CD40 LIGAND; GRANULOCYTE COLONY STIMULATING FACTOR;

ANIMAL EXPERIMENT; ARTICLE; BLOOD DONOR; BLOOD TRANSFUSION; BONE MARROW CELL; CELL ISOLATION; CHIMERA; CONTROLLED STUDY; FEMALE; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; MOUSE; NONHUMAN; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; T LYMPHOCYTE; WHOLE BODY RADIATION;

ANIMALS; BONE MARROW CELLS; FEMALE; FLOW CYTOMETRY; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELLS; IMMUNE TOLERANCE; IMMUNOSUPPRESSIVE AGENTS; MICE; MICE, INBRED C57BL; STEM CELL TRANSPLANTATION; STEM CELLS; T-LYMPHOCYTES; TRANSPLANTATION CHIMERA; TRANSPLANTATION TOLERANCE;

EID: 51849155023     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2008.02371.x     Document Type: Article

References (50)

1. Wekerle T, Sykes M. Mixed chimerism and transplantation tolerance. Annu Rev Med 2001 52 : 353 370.
2. Sharabi Y, Sachs DH. Mixed chimerism and permanent specific transplantation tolerance induced by a non-lethal preparative regimen. J Exp Med 1989 169 : 493 502.
3. Tomita Y, Sachs DH, Khan A, Sykes M. Additional mAb injections can replace thymic irradiation to allow induction of mixed chimerism and tolerance in mice receiving bone marrow transplantation after conditioning with anti-T cell mAbs and 3 Gy whole body irradiation. Transplantation 1996 61 : 469 477.
4. Huang CA, Fuchimoto Y, Scheier-Dolberg R, Murphy MC, Neville DM Jr., Sachs DH. Stable mixed chimerism and tolerance using a nonmyeloablative preparative regimen in a large-animal model. J Clin Invest 2000 105 : 173 181.
5. Wekerle T, Nikolic B, Pearson DA, Swenson KG, Sykes M. Minimal conditioning required in a murine model of T cell depletion, thymic irradiation and high-dose bone marrow transplantation for the induction of mixed chimerism and tolerance. Transpl Int 2002 15 : 248 253.
6. Sykes M, Szot GL, Swenson K, Pearson DA. Induction of high levels of allogeneic hematopoietic reconstitution and donor-specific tolerance without myelosuppressive conditioning. Nature Med 1997 3 : 783 787.
7. Fuchimoto Y, Huang CA, Shimizu A et al. Mixed chimerism without whole body irradiation in a large animal model. J Clin Invest 2000 105 : 1779 1789.
8. Pree I, Wekerle T. New approaches to prevent transplant rejection: Co-stimulation blockers anti-CD40L and CTLA4Ig. Drug Discov Today: Ther Strat 2006 3 : 41 47.
9. Snanoudj R, de Preneuf H, Creput C et al. Costimulation blockade and its possible future use in clinical transplantation. Transpl Int 2006 19 : 693 704.
10. Wekerle T, Sayegh MH, Hill J et al. Extrathymic T cell deletion and allogeneic stem cell engraftment induced with costimulatory blockade is followed by central T cell tolerance. J Exp Med 1998 187 : 2037 2044.
11. Adams AB, Durham MM, Kean L et al. Costimulation blockade, busulfan, and bone marrow promote titratable macrochimerism, induce transplantation tolerance, and correct genetic hemoglobinopathies with minimal myelosuppression. J Immunol 2001 167 : 1103 1111.
12. Westerhuis G, Maas WGE, Willemze R, Toes REM, Fibbe WE. Long-term mixed chimerism after immunologic conditioning and MHC-mismatched stem-cell transplantation is dependent on NK-cell tolerance. Blood 2005 106 : 2215 2220.
13. Seung E, Iwakoshi N, Woda BA et al. Allogeneic hematopoietic chimerism in mice treated with sublethal myeloablation and anti-CD154 antibody: Absence of graft-versus-host disease, induction of skin allograft tolerance, and prevention of recurrent autoimmunity in islet-allografted NOD/Lt mice. Blood 2000 95 : 2175 2182.
14. Quesenberry PJ, Zhong S, Wang H, Stewart M. Allogeneic chimerism with low-dose irradiation, antigen presensitization, and costimulator blockade in H-2 mismatched mice. Blood 2001 97 : 557 564.
15. Blaha P, Bigenzahn S, Koporc Z et al. The influence of immunosuppressive drugs on tolerance induction through bone marrow transplantation with costimulation blockade. Blood 2003 101 : 2886 2893.
16. Wekerle T, Kurtz J, Ito H et al. Allogeneic bone marrow transplantation with co-stimulatory blockade induces macrochimerism and tolerance without cytoreductive host treatment. Nature Med 2000 6 : 464 469.
17. Durham MM, Bingaman AW, Adams AB et al. Administration of anti-CD40 ligand and donor bone marrow leads to hematopoietic chimerism and donor-specific tolerance without cytoreductive conditioning. J Immunol 2000 165 : 1 4.
18. Kean LS, Hamby K, Koehn B et al. NK cells mediate costimulation blockade-resistant rejection of allogeneic stem cells during nonmyeloablative transplantation. Am J Transplant 2006 6 : 292 304.
19. Blaha P, Bigenzahn S, Koporc Z, Sykes M, Muehlbacher F, Wekerle T. Short-term immunosuppression facilitates induction of mixed chimerism and tolerance after bone marrow transplantation without cytoreductive conditioning. Transplantation 2005 80 : 237 243.
20. Graca L, Daley S, Fairchild P, Cobbold S, Waldmann H. Co-receptor and co-stimulation blockade for mixed chimerism and tolerance without myelosuppressive conditioning. BMC Immunology 2006 7 : 9.
21. Copelan EA. Hematopoietic stem-cell transplantation. N Engl J Med 2006 345 : 1813 1826.
22. Korbling M, Anderlini P. Peripheral blood stem cell versus bone marrow allotransplantation: Does the source of hematopoietic stem cells matter? Blood 2001 98 : 2900 2908.
23. Arpinati M, Green CL, Heimfeld S, Heuser JE, Anasetti C. Granulocyte-colony stimulating factor mobilizes T helper 2-inducing dendritic cells. Blood 2000 95 : 2484 2490.
24. Cutler C, Antin JH. Peripheral blood stem cells for allogeneic transplantation: A review. Stem Cells 2001 19 : 108 117.
25. Gyger M, Stuart RK, Perreault C. Immunobiology of allogeneic peripheral blood mononuclear cells mobilized with granulocyte-colony stimulating factor. Bone Marrow Transplant 2000 26 : 1 16.
26. Pan L, Delmonte J, Jalonen CK, Ferrara JLM. Pretreatment of donor mice with granulocytes colony-stimulating factor polarizes donor T lymphocytes toward type-2 cytokine production and reduces severity of experimental graft-vs-host disease. Blood 1996 86 : 4422 4429.
27. Sloand EM, Kim S, Maciejewski JP et al. Pharmacologic doses of granulocyte colony-stimulating factor affect cytokine production by lymphocytes in vitro and in vivo. Blood 2000 95 : 2269 2274.
28. Koporc Z, Bigenzahn S, Blaha P et al. Induction of mixed chimerism through transplantation of CD45-congenic mobilized peripheral blood stem cells after nonmyeloablative irradiation. Biol Blood Marrow Transplant 2006 12 : 284 292.
29. Morrison SJ, Wright DE, Weissman IL. Cyclophosphamide/granulocyte colony-stimulating factor induces hematopoietic stem cells to proliferate prior to mobilization. Proc Natl Acad Sci USA 1997 94 : 1908 1913.
30. Bigenzahn S, Blaha P, Koporc Z et al. The role of non-deletional tolerance mechanisms in a murine model of mixed chimerism with costimulation blockade. Am J Transplant 2005 5 : 1237 1247.
31. Pree I, Bigenzahn S, Fuchs D et al. CTLA4Ig promotes the induction of hematopoietic chimerism and tolerance independently of indoleamine-2,3- dioxygenase (IDO). Transplantation 2007 83 : 663 667.
32. + T-cell-mediated alloresistance to allogeneic marrow in recipients of anti-CD40 L. Am J Transplant 2004 4 : 31 40.
33. Kishimoto K, Dong VM, Issazadeh S et al. The role of CD154-CD40 versus CD28-B7 costimulatory pathways in regulating allogeneic Th1 and Th2 responses in vivo. J Clin Invest 2000 106 : 63 72.
34. Wekerle T, Kurtz J, Bigenzahn S, Takeuchi Y, Sykes M. Mechanisms of transplant tolerance induction using costimulatory blockade. Curr Opin Immunol 2002 14 : 592 600.
35. Ringden O, Remberger M, Runde V et al. Peripheral blood stem cell transplantation from unrelated donors: A comparison with marrow transplantation. Blood 1999 94 : 455 464.
36. Martin PJ, Hansen JA, Buckner CD et al. Effects of in vitro depletion of T cells in HLA-identical allogeneic marrow grafts. Blood 1985 66 : 664 672.
37. Martin PJ, Hansen JA, Torok-Storb B et al. Graft failure in patients receiving T cell-depleted HLA-identical allogeneic marrow transplants. Bone Marrow Transplant 1988 3 : 445 456.
38. Pirsch JD, Maki DG. Infectious complications in adults with bone marrow transplantation and T-cell depletion of donor marrow. Increased susceptibility to fungal infections. Ann Intern Med 1986 104 : 619 631.
39. Seidl MG, Fritsch G, Matthes-Martin S et al. In vitro an in vivo T-cell depletion with myeloablative or reduced-intensity conditioning in pediatric hematopoietic stem cell transplantation. Haematologica 2005 90 : 1405 1414.
40. Taylor PA, Lees CJ, Wilson JM et al. Combined effects of calcineurin inhibitors or sirolimus with anti-CD40 L mAb on alloengraftment under nonmyeloablative conditions. Blood 2002 100 : 3400 3407.
41. Seung E, Mordes JP, Rossini AA, Greiner DL. Hematopoietic chimerism and central tolerance created by peripheral-tolerance induction without myeloablative conditioning. J Clin Invest 2003 112 : 795 808.
42. Ashton-Chess J, Brouard S, Soulillou J-P. Is clinical tolerance realistic in the next decade? Transpl Int 2006 19 : 539 548.
43. Pelot MR, Pearson DA, Swenson K et al. Lymphohematopoietic graft-vs-host reactions can be induced without graft-vs-host disease in murine mixed chimeras established with a cyclophosphamide-based non-myeloablative conditioning regimen. Biol Blood Marrow Transplant 1999 5 : 133 143.
44. Kim Y-M, Mapara MY, Down JD et al. Graft-versus-host-reactive donor CD4 cells can induce T cell-mediated rejection of the donor marrow in mixed allogeneic chimeras prepared with nonmyeloablative conditioning. Blood 2004 103 : 732 739.
45. Heitger A, Blaha P, Bigenzahn S, Muehlbacher F, Wekerle T. The influence of immunosuppressive drugs on cell-induced graft tolerance. Curr Opin Organ Transplant 2004 9 : 307 313.
46. Konieczny BT, Dai Z, Elwood ET et al. IFN-g is critical for long-term allograft survival induced by blocking the CD28 and CD40 ligand T cell costimulation pathways. J Immunol 1998 160 : 2059 2064.
47. Colby C, Chang Q, Fuchimoto Y et al. Cytokine-mobilized peripheral blood progenitor cells for allogeneic reconstitution of miniature swine. Transplantation 2000 69 : 135 140.
48. Buhler L, Awwad M, Treter S et al. Pig hematopoietic cell chimerism in baboons conditioned with a nonmyeloablative regiment and CD154 blockade. Transplantation 2002 73 : 12 22.
49. Gleit ZL, Fuchimoto Y, Yamada K et al. Variable relationship between chimerism and tolerance after hematopoietic cell transplantation without myelosuppressive conditioning. Transplantation 2002 74 : 1535 1544.
50. Kean LS, Adams AB, Strobert E et al. Induction of chimerism in rhesus macaques through stem cell transplant and costimulation blockade-based immunosuppression. Am J Transplant 2007 7 : 320 335.